sevoflurane has been researched along with Muscle Contraction in 43 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare acceleromyography (AMG) and electromyography (EMG) with xenon or sevoflurane anesthesia during vecuronium-induced neuromuscular blockade." | 9.08 | Comparison of acceleromyography and electromyography in vecuronium-induced neuromuscular blockade with xenon or sevoflurane anesthesia. ( Goto, T; Ichinose, F; Morita, S; Nakata, Y; Saito, H; Suwa, K; Uezono, S, 1998) |
| "To examine the effects of discontinuing sevoflurane or isoflurane anesthesia (1 minimum alveolar anesthetic concentration [MAC] of end-tidal concentrations, together with 66% N2O/O2) on the reversal of vecuronium-induced neuromuscular blockade (an initial dose = 100 micrograms/kg), the electromyographic response of the abductor digiti minimi was monitored at 20-s intervals after train-of-four (TOF) stimulation of the ulnar nerve in 192 ASA grades I and II patients." | 7.69 | Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. ( Fujita, T; Morita, T; Saito, S; Sato, H; Sugaya, T; Tsukagoshi, H, 1995) |
| "To compare acceleromyography (AMG) and electromyography (EMG) with xenon or sevoflurane anesthesia during vecuronium-induced neuromuscular blockade." | 5.08 | Comparison of acceleromyography and electromyography in vecuronium-induced neuromuscular blockade with xenon or sevoflurane anesthesia. ( Goto, T; Ichinose, F; Morita, S; Nakata, Y; Saito, H; Suwa, K; Uezono, S, 1998) |
| " Tyrosine kinase-catalyzed protein tyrosine phosphorylation plays an important role in regulating vascular smooth muscle contraction." | 3.73 | Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction. ( Hasegawa, A; Hatano, Y; Kakutani, T; Mizumoto, K; Ogawa, K; Yu, J, 2005) |
| " Angiotensin II (Ang II) is one of the primary regulators of vascular tension and arterial blood pressure, and the p44/42 mitogen-activated protein kinases (p44/42 MAPK) are involved in Ang II-mediated vascular smooth muscle contraction." | 3.73 | The inhibitory effects of sevoflurane on angiotensin II- induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle. ( Hatano, Y; Mizumoto, K; Ogawa, K; Tokinaga, Y; Yu, J, 2005) |
| "Because exposure to low temperature can modify the effect of volatile anesthetics on airway smooth muscle contraction, this study was conducted to investigate low-temperature modifications of the inhibitory effects of isoflurane and sevoflurane on canine tracheal smooth muscle tone by simultaneously measuring the muscle tension and intracellular concentration of Ca2+ ([Ca2+]i) and by measuring voltage-dependent Ca2+ channel activity." | 3.70 | Low-temperature modification of the inhibitory effects of volatile anesthetics on airway smooth muscle contraction in dogs. ( Hattori, J; Kamada, Y; Namiki, A; Tsujiguchi, N; Yamakage, M, 2000) |
| "We investigated the direct interaction between the volatile anesthetics, isoflurane and sevoflurane, and hypoxia in porcine tracheal smooth muscle in vitro by simultaneously measuring muscle tension and intracellular concentration of free Ca(2+) ([Ca2+]i)." | 3.70 | Interaction between volatile anesthetics and hypoxia in porcine tracheal smooth muscle. ( Chen, X; Kamada, Y; Namiki, A; Tsujiguchi, N; Yamakage, M, 2000) |
| "To examine the effects of discontinuing sevoflurane or isoflurane anesthesia (1 minimum alveolar anesthetic concentration [MAC] of end-tidal concentrations, together with 66% N2O/O2) on the reversal of vecuronium-induced neuromuscular blockade (an initial dose = 100 micrograms/kg), the electromyographic response of the abductor digiti minimi was monitored at 20-s intervals after train-of-four (TOF) stimulation of the ulnar nerve in 192 ASA grades I and II patients." | 3.69 | Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. ( Fujita, T; Morita, T; Saito, S; Sato, H; Sugaya, T; Tsukagoshi, H, 1995) |
| "Rocuronium was administered in increments of 100 micrograms." | 2.69 | Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. ( Ledowski, T; Linstedt, U; Proppe, D; Sitzlack, D; Wulf, H, 1998) |
| "Sevoflurane is a common operating room anesthetic and can be used in the intensive care medicine as well." | 1.42 | Sevoflurane exposure prevents diaphragmatic oxidative stress during mechanical ventilation but reduces force and affects protein metabolism even during spontaneous breathing in a rat model. ( Bergs, I; Bleilevens, C; Breuer, T; Bruells, CS; Gayan-Ramirez, G; Maes, K; Marx, G; Rossaint, R; Scheers, H, 2015) |
| "Sevoflurane is a known triggering agent of malignant hyperthermia (MH)." | 1.39 | Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. ( Heiderich, S; Johannsen, S; Klingler, W; Roewer, N; Schneiderbanger, D; Schuster, F, 2013) |
| "Halothane was the strongest discriminator for malignant hyperthermia in the in-vitro contracture tests." | 1.37 | In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced? ( Anetseder, M; Kranke, P; Metterlein, T; Roewer, N; Schuster, F, 2011) |
| "To diagnose malignant hyperthermia (MH) susceptibility, muscle bundles are exposed to halothane and caffeine." | 1.37 | Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( Anetseder, M; Hartung, E; Metterlein, T; Roewer, N; Schuster, F, 2011) |
| "The sevoflurane-induced increase in cyclic adenosine monophosphate that was seen in the control and ovalbumin-sensitized groups was significantly suppressed in the chronic cigarette-smoking group." | 1.33 | Different inhibitory effects of sevoflurane on hyperreactive airway smooth muscle contractility in ovalbumin-sensitized and chronic cigarette-smoking guinea pig models. ( Iwasaki, S; Namiki, A; Satoh, J; Yamakage, M, 2006) |
| "The diagnosis of malignant hyperthermia susceptibility relies on the in vitro contracture test on skeletal muscle." | 1.31 | Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane. ( Dirksen, R; Gielen, MJ; Snoeck, MM; Tangerman, A; van Egmond, J, 2000) |
| "Sevoflurane responses were repeated at concentrations with no effect on spontaneous contractility of TEA, a Ca(2+)-activated K(+) channel blocker, and glibenclamide, an adenosine triphosphate-sensitive K(+) channel blocker, in myometrial strips." | 1.31 | The role of K(+) channels on the inhibitor effect of sevoflurane in pregnant rat myometrium. ( Bagcivan, I; Gürsoy, S; Kafali, H; Karadas, B; Kaya, T; Sarioglu, Y, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (37.21) | 18.2507 |
| 2000's | 18 (41.86) | 29.6817 |
| 2010's | 9 (20.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsui, M | 1 |
| Konishi, J | 1 |
| Suzuki, T | 1 |
| Sekijima, C | 1 |
| Miyazawa, N | 1 |
| Yamamoto, S | 1 |
| Ye, L | 1 |
| Sun, XX | 1 |
| Zhu, T | 1 |
| Yang, PL | 1 |
| Johannsen, S | 1 |
| Klingler, W | 1 |
| Schneiderbanger, D | 1 |
| Heiderich, S | 1 |
| Roewer, N | 3 |
| Schuster, F | 3 |
| Breuer, T | 1 |
| Maes, K | 1 |
| Rossaint, R | 1 |
| Marx, G | 1 |
| Scheers, H | 1 |
| Bergs, I | 1 |
| Bleilevens, C | 1 |
| Gayan-Ramirez, G | 1 |
| Bruells, CS | 1 |
| Metterlein, T | 2 |
| Kranke, P | 1 |
| Anetseder, M | 2 |
| Shimogai, M | 1 |
| Ogawa, K | 5 |
| Tokinaga, Y | 4 |
| Yamazaki, A | 1 |
| Hatano, Y | 5 |
| Uematsu, N | 1 |
| Tange, K | 1 |
| Hartung, E | 1 |
| Ammoury, RF | 1 |
| Emhardt, JD | 1 |
| Aitchison, WB | 1 |
| Horn, DS | 1 |
| Croffie, JM | 1 |
| Turner, RJ | 1 |
| Lambrost, M | 1 |
| Holmes, C | 1 |
| Katz, SG | 1 |
| Downs, CS | 1 |
| Collins, DW | 1 |
| Gatt, SP | 1 |
| Motamed, C | 1 |
| Donati, F | 1 |
| Thorlacius, K | 1 |
| Zhoujun, C | 1 |
| Bodelsson, M | 1 |
| Yu, J | 3 |
| Hannon, JD | 1 |
| Cody, MJ | 1 |
| Sun, DX | 1 |
| Housmans, PR | 1 |
| Hattori, J | 2 |
| Yamakage, M | 5 |
| Seki, S | 1 |
| Okazaki, K | 1 |
| Namiki, A | 5 |
| Uesugi, T | 1 |
| Mikawa, K | 2 |
| Nishina, K | 2 |
| Kodama, SI | 1 |
| Obara, H | 2 |
| Mizumoto, K | 2 |
| Kakutani, T | 1 |
| Hasegawa, A | 1 |
| Iwasaki, S | 1 |
| Satoh, J | 1 |
| Bonciu, M | 1 |
| de la Chapelle, A | 1 |
| Delpech, H | 1 |
| Depret, T | 1 |
| Krivosic-Horber, R | 1 |
| Aimé, MR | 1 |
| Kuczkowski, KM | 1 |
| Morita, T | 1 |
| Tsukagoshi, H | 1 |
| Sugaya, T | 1 |
| Saito, S | 1 |
| Sato, H | 1 |
| Fujita, T | 1 |
| Yamaguchi, A | 1 |
| Okabe, E | 1 |
| Kaplan, RF | 1 |
| Garcia, M | 1 |
| Hannallah, RS | 1 |
| Yamazaki, M | 1 |
| Momose, Y | 1 |
| Ito, Y | 1 |
| Saitoh, Y | 2 |
| Toyooka, H | 1 |
| Amaha, K | 2 |
| Kohro, S | 1 |
| Kawamata, T | 1 |
| Kagawa, T | 1 |
| Maekawa, N | 1 |
| Yaku, H | 1 |
| Nakata, Y | 1 |
| Goto, T | 1 |
| Saito, H | 1 |
| Ichinose, F | 1 |
| Uezono, S | 1 |
| Suwa, K | 1 |
| Morita, S | 1 |
| Wulf, H | 1 |
| Ledowski, T | 1 |
| Linstedt, U | 1 |
| Proppe, D | 1 |
| Sitzlack, D | 1 |
| Kai, T | 1 |
| Bremerich, DH | 1 |
| Jones, KA | 1 |
| Warner, DO | 1 |
| Tanaka, H | 1 |
| Fujii, Y | 1 |
| Makita, K | 1 |
| Vinh, VH | 1 |
| Enoki, T | 1 |
| Hirata, S | 1 |
| Toda, H | 1 |
| Kakuyama, M | 1 |
| Nakamura, K | 1 |
| Fukuda, K | 1 |
| Wiklund, CU | 1 |
| Lim, S | 1 |
| Lindsten, U | 1 |
| Lindahl, SG | 1 |
| Snoeck, MM | 1 |
| Gielen, MJ | 1 |
| Tangerman, A | 1 |
| van Egmond, J | 1 |
| Dirksen, R | 1 |
| Tsujiguchi, N | 2 |
| Kamada, Y | 2 |
| Chen, X | 1 |
| Eikermann, M | 1 |
| Renzing-Köhler, K | 1 |
| Peters, J | 1 |
| Kafali, H | 1 |
| Kaya, T | 1 |
| Gürsoy, S | 1 |
| Bagcivan, I | 1 |
| Karadas, B | 1 |
| Sarioglu, Y | 1 |
| Ide, T | 3 |
| Kochi, T | 2 |
| Isono, S | 3 |
| Mizuguchi, T | 3 |
| Kaneko, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures: Does it Increase Blood Loss and Interventions for Blood Loss and Why Do Anesthesiologists Choose to Use It?[NCT01048658] | Phase 4 | 160 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01048658)
Timeframe: Post-procedure, within 30 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 13 |
| No Sevoflurane | 11 |
Provider report for need to intervene due to blood loss (yes/no) (NCT01048658)
Timeframe: At time of uterine evacuation and immediately post-operatively, an average of 7.1 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 20 |
| No Sevoflurane | 13 |
Procedural blood loss greater than 300 mL. Blood loss was measured in a standardized fashion (amniotic fluid was discarded, blood was separated from tissue, and all gauze surgical drapes weighed). (NCT01048658)
Timeframe: At time of uterine evacuation, an average of 7.1 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 12 |
| No Sevoflurane | 6 |
Length of procedure from time of speculum placement to time of speculum removal, in minutes. (NCT01048658)
Timeframe: Time of speculum place to time of speculum removal, an average of 7.1 minutes
| Intervention | minutes (Mean) |
|---|---|
| Sevoflurane | 7.0 |
| No Sevoflurane | 7.3 |
Scores reported on 10-cm Visual Analog Scale (VAS anchors: 0= not satisfied at all, 10= completely satisfied) . Reported as mean +/- standard deviation. Subjects and providers were blinded to anesthesia method. Subjects and providers completed post-operative questionnaire within 30 minutes of procedure completion. (NCT01048658)
Timeframe: Post-procedure, within 30 minutes
| Intervention | cm (Mean) | |
|---|---|---|
| Provider Satisfaction | Patient Satisfaction | |
| No Sevoflurane | 9.3 | 8.2 |
| Sevoflurane | 9.4 | 8.4 |
7 trials available for sevoflurane and Muscle Contraction
| Article | Year |
|---|---|
Reversibility of Rocuronium-Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study.
Topics: Analgesics, Opioid; Anesthesia; Anesthesia Recovery Period; Child; Humans; Infant; Muscle Contractio | 2019 |
Can colonic manometry studies be done on the day of colonic motility catheter placement?
Topics: Adolescent; Anesthetics; Anesthetics, Inhalation; Anesthetics, Intravenous; Catheterization; Cathete | 2012 |
Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time.
Topics: Adult; Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Drug Synergism; | 2002 |
Comparison of acceleromyography and electromyography in vecuronium-induced neuromuscular blockade with xenon or sevoflurane anesthesia.
Topics: Acceleration; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthesia, Inhalation; Anest | 1998 |
Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Topics: Adult; Androstanols; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intravenous; An | 1998 |
Post-tetanic burst count and train-of-four during recovery from vecuronium-induced intense neuromuscular block under different types of anaesthesia.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Inhalation; Anesthetics, Inhalat | 1998 |
Probability of acceptable intubation conditions with low dose rocuronium during light sevoflurane anaesthesia in children.
Topics: Androstanols; Anesthesia, Inhalation; Anesthetics, Inhalation; Child; Child, Preschool; Dose-Respons | 2001 |
36 other studies available for sevoflurane and Muscle Contraction
| Article | Year |
|---|---|
[The Effect of Emulsified Sevofluran on Muscular Relaxation through Selective Blockage of Peripheral Nerves].
Topics: Anesthetics, Inhalation; Animals; Methyl Ethers; Muscle Contraction; Muscle, Skeletal; Nerve Block; | 2016 |
Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Topics: Anesthetics, Inhalation; Biopsy; Disease Susceptibility; Dose-Response Relationship, Drug; Genetic P | 2013 |
Sevoflurane exposure prevents diaphragmatic oxidative stress during mechanical ventilation but reduces force and affects protein metabolism even during spontaneous breathing in a rat model.
Topics: Anesthetics, Inhalation; Animals; Antioxidants; Calpain; Caspase 3; Diaphragm; Forkhead Transcriptio | 2015 |
In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
Topics: Anesthetics, Inhalation; Biopsy; Case-Control Studies; Desflurane; Dose-Response Relationship, Drug; | 2011 |
The cellular mechanisms underlying the inhibitory effects of isoflurane and sevoflurane on arginine vasopressin-induced vasoconstriction.
Topics: Actin Cytoskeleton; Anesthetics, Inhalation; Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium | 2010 |
Sevoflurane inhibits angiotensin II-induced Rho kinase-mediated contraction of vascular smooth muscle from spontaneously hypertensive rat.
Topics: Amides; Anesthetics, Inhalation; Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium; | 2011 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Topics: Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; Dose-R | 2011 |
The effects of sevoflurane on isolated gravid human myometrium.
Topics: Analysis of Variance; Anesthesia, Obstetrical; Culture Techniques; Dose-Response Relationship, Drug; | 2002 |
Effects of sevoflurane on sympathetic neurotransmission in human omental arteries and veins.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Inhalation; Dose-Response Relationship, Drug; Electric | 2003 |
Sevoflurane inhibits guanosine 5'-[gamma-thio]triphosphate-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle.
Topics: Amides; Anesthetics, Inhalation; Animals; Aorta, Thoracic; Cell Membrane; Cytosol; Enzyme Inhibitors | 2003 |
Effects of isoflurane and sevoflurane on intracellular calcium and contractility in pressure-overload hypertrophy.
Topics: Aequorin; Anesthetics, Inhalation; Animals; Blood Pressure; Blotting, Western; Calcium; Electric Sti | 2004 |
Inhibitory effects of the anesthetics propofol and sevoflurane on spontaneous lymphatic vessel activity in rats.
Topics: Acetylcholine; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Coloring Agents; Depressi | 2004 |
Effects of phosphodiesterase-III inhibitors on sevoflurane-induced impairment of rat diaphragmatic function.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Anesthetics, Inhalation; Animals; Cyclic AMP; Cyclic Nucleotide | 2005 |
Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction.
Topics: Anesthetics, Inhalation; Animals; Aorta, Thoracic; Enzyme Inhibitors; Genistein; In Vitro Techniques | 2005 |
The inhibitory effects of sevoflurane on angiotensin II- induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle.
Topics: Anesthetics, Inhalation; Angiotensin II; Animals; Aorta, Thoracic; Blotting, Western; Dose-Response | 2005 |
Different inhibitory effects of sevoflurane on hyperreactive airway smooth muscle contractility in ovalbumin-sensitized and chronic cigarette-smoking guinea pig models.
Topics: Airway Resistance; Anesthetics, Inhalation; Animals; Bronchial Hyperreactivity; Calcium Channels; Cy | 2006 |
Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Biopsy; Body Temperature; Carbon Dioxide; Child; | 2007 |
Anesthetic implications of botulinum toxin type A (Botox) injections for the treatment of 'the aging face' in the parturient.
Topics: Adult; Aging; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Obstetrical; Anesthetics, | 2007 |
Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia.
Topics: Adult; Anesthesia; Anesthetics; Dose-Response Relationship, Drug; Ethers; Female; Humans; Isoflurane | 1995 |
Effect of sevoflurane on the vascular reactivity of rabbit mesenteric artery.
Topics: Acetylcholine; Anesthetics; Animals; Dose-Response Relationship, Drug; Drug Synergism; Ethers; In Vi | 1995 |
Mivacurium-induced neuromuscular blockade during sevoflurane and halothane anaesthesia in children.
Topics: Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthetics, Inhalation; Child; Child, Preschool | 1995 |
[Effects of sevoflurane or halothane on contractile responses of isolated canine basilar artery].
Topics: Animals; Basilar Artery; Dogs; Ethers; Halothane; In Vitro Techniques; Methyl Ethers; Muscle Contrac | 1994 |
Relationship between post-tetanic twitch and single twitch response after administration of vecuronium.
Topics: Adult; Anesthesia, Inhalation; Anesthetics; Enflurane; Ethers; Female; Halothane; Humans; Isoflurane | 1993 |
Inhibitory effects of four inhaled anesthetics on canine tracheal smooth muscle contraction and intracellular Ca2+ concentration.
Topics: Anesthetics; Animals; Calcium; Carbachol; Dogs; Drug Interactions; Enflurane; Ethers; Halothane; Iso | 1993 |
The effect of halothane and sevoflurane on fatigue-induced changes in hamster diaphragmatic contractility.
Topics: Anesthetics, Inhalation; Animals; Cricetinae; Diaphragm; Ethers; Halothane; In Vitro Techniques; Mal | 1998 |
Drug-specific effects of volatile anesthetics on Ca2+ sensitization in airway smooth muscle.
Topics: Acetylcholine; Anesthetics, Inhalation; Animals; Calcium; Dogs; Escin; Female; Guanosine Triphosphat | 1998 |
Comparative contractile effects of halothane and sevoflurane in rat aorta.
Topics: Anesthetics, Inhalation; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Drug Interacti | 2000 |
Relaxation by sevoflurane, desflurane and halothane in the isolated guinea-pig trachea via inhibition of cholinergic neurotransmission.
Topics: Acetylcholine; Anesthetics, Inhalation; Animals; Cholinergic Fibers; Culture Techniques; Desflurane; | 1999 |
Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
Topics: Anesthetics, Inhalation; Caffeine; Humans; In Vitro Techniques; Malignant Hyperthermia; Methyl Ether | 2000 |
Low-temperature modification of the inhibitory effects of volatile anesthetics on airway smooth muscle contraction in dogs.
Topics: Anesthetics, Inhalation; Animals; Calcium Channels; Cold Temperature; Dogs; Dose-Response Relationsh | 2000 |
Interaction between volatile anesthetics and hypoxia in porcine tracheal smooth muscle.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Calcium; Calcium Signaling; Carbachol; Chela | 2000 |
The role of K(+) channels on the inhibitor effect of sevoflurane in pregnant rat myometrium.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Dose-Response Relationship, Drug; Female; | 2002 |
Effect of sevoflurane on diaphragmatic contractility in dogs.
Topics: Anesthetics; Animals; Blood Pressure; Diaphragm; Dogs; Dose-Response Relationship, Drug; Electric St | 1992 |
Diaphragmatic function during sevoflurane anaesthesia in dogs.
Topics: Abdomen; Anesthesia, Inhalation; Anesthetics; Animals; Blood Pressure; Carbon Dioxide; Catheterizati | 1991 |
[Effects of sevoflurane and enflurane on isometric tension and maximum velocity of shortening in glycerinated guinea pig masseter muscles].
Topics: Anesthetics; Animals; Ethers; Guinea Pigs; In Vitro Techniques; Isoflurane; Masseter Muscle; Methyl | 1990 |
Effects of sevoflurane and enflurane on contractility of canine diaphragm.
Topics: Anesthetics; Animals; Diaphragm; Dogs; Dose-Response Relationship, Drug; Enflurane; Ethers; Methyl E | 1990 |